Latest standards
Our new standards and reference materials are now available to order.
New Release: May 2026
Infectious Diseases
|
Product code
|
Product name
|
|
25/274
|
4th Pneumococcal Validation Serum Panel
|
Monoclonal antibodies
|
Product code
|
Product name
|
|
19/264
|
1st International Standard 2025 Anti-drug antibodies to adalimumab (neutralisation assays)
|
|
19/266
|
1st International Standard 2025 Anti-drug antibodies to adalimumab (binding assays)
|
|
FS-007
|
WHO International Reference Reagent Anti-drug antibodies to adalimumab (detection of low activity)
|
|
FS-008
|
WHO International Reference Reagent Anti-drug antibodies to adalimumab (detection of low affinity)
|
Blood products
|
Product code
|
Product name
|
|
24/114
|
Thromboplastin Human, Recombinant (RTF)
|
Influenza
|
Product code
|
Product name
|
|
23/144
|
1st WHO International Standard for Antibodies to Influenza A Virus Group 1 HA Stem Domain for binding assays
|
|
25/280
|
Influenza Virus Infectious B/Austria/1359417/2021 (B-Victoria)
|
|
25/282
|
Influenza Virus Infectious SAN-046 A/Missouri/11/2025 (H1N1 pdm09)
|
|
25/296
|
Influenza Virus Infectious A/Darwin/1454/2025 (H3N2)
|
|
25/298
|
Influenza Virus Infectious A/Michigan/105/2025 (H3N2)
|
|
25/320
|
Influenza Antigen A/Missouri/11/2025 (IVR-279) (H1N1)
|
|
25/318
|
Influenza Virus Infectious A/Darwin/1499/2025 (H3N2)
|
|
25/324
|
Influenza Virus Infectious IVR-285 (A/Michigan/105/2025) (H3N2)
|
|
25/326
|
Influenza Virus Infectious SAN-049A (A/Michigan/105/2025) (H3N2)
|
|
25/292
|
Influenza Virus Infectious CNIC-2601 (A/Sichuan-Pingshan/323/2025) (H3N2)
|
|
25/294
|
Influenza Virus Infectious CNIC-2602A (A/Shanghai-Huangpu/12925/2025) (H3N2)
|
|
25/300
|
Influenza Virus Infectious B/Tokyo/EIS13-175/2025 (B/Victoria)
|
|
25/302
|
Influenza Virus Infectious B/Tokyo/EIS13-011/2025 (B/Victoria)
|
|
25/304
|
Influenza Virus Infectious IVR-283 (A/Darwin/1454/2025) (H3N2)
|
|
25/306
|
Influenza Virus Infectious IVR-284 (A/Darwin/1499/2025) (H3N2)
|
|
25/328
|
Influenza Virus Infectious B/Perth/115/2025 (B/Victoria)
|
|
26/100
|
Influenza Antigen A/ Michigan/105/2025 (IVR-285) (H3N2)
|
|
26/102
|
Influenza Antigen A/Michigan/105/2025 (SAN-49A) (H3N2)
|
|
26/104
|
Influenza Antigen B/Tokyo/EIS13-175/2025 (B Victoria lineage)
|
|
26/108
|
Influenza A/Darwin/1454/2025 - like (H3N2) HA serum
|
|
26/110
|
Influenza B/Tokyo/EIS13-175/2025 - like (B Victoria lineage) HA serum
|